Showing 1 - 4 results of 4 for search 'Narvekar A', query time: 0.02s Refine Results
  1. 1
    Efficacy and safety of olopatadine hydrochloride 0.77% in patients with allergic conjunctivitis using a conjunctival allergen-challenge model

    Efficacy and safety of olopatadine hydrochloride 0.77% in patients with allergic conjunctivitis using a conjunctival allergen-challenge model by Torkildsen G, Narvekar A, Bergmann M

    Published 2015-09-01
    Get full text
    Article
  2. 2
    A randomized controlled trial of povidone-iodine/dexamethasone ophthalmic suspension for acute viral conjunctivitis

    A randomized controlled trial of povidone-iodine/dexamethasone ophthalmic suspension for acute viral conjunctivitis by Pepose JS, Narvekar A, Liu W, Haque R

    Published 2019-03-01
    Get full text
    Article
  3. 3
    Pooled analysis of two studies evaluating efficacy and safety of olopatadine hydrochloride 0.77% in patients with allergic conjunctivitis

    Pooled analysis of two studies evaluating efficacy and safety of olopatadine hydrochloride 0.77% in patients with allergic conjunctivitis by McLaurin E, Bergmann M, Narvekar A, Adewale A, Gomes P, Torkildsen G

    Published 2017-06-01
    Get full text
    Article
  4. 4
    Pharmacokinetics and safety of olopatadine hydrochloride 0.77% in healthy subjects with asymptomatic eyes: data from 2 independent clinical studies

    Pharmacokinetics and safety of olopatadine hydrochloride 0.77% in healthy subjects with asymptomatic eyes: data from 2 independent clinical studies by Meier E, Narvekar A, Iyer GR, DuBiner HB, Vutikullird A, Wirta D, Sall K

    Published 2017-04-01
    Get full text
    Article

Search Tools: